文献速递乳腺癌放疗放疗物理与技术

早期乳腺癌标准治疗中辅助放疗疗程的自付费用建模:比较医疗补助与医疗保险计划

Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration in Standard-of-Care Early Stage Breast Cancer Treatment Across Medicaid and Medicare Plans.
PubMed 文献 · Pract Radiat Oncol · 2023-09-24

该研究基于美国俄亥俄州医院场景,按国家综合癌症网络指南确定1周(5次)与3周(15次)放疗方案,利用医保计划官方数据计算医疗补助、原始医疗保险、Medigap G计划和Medicare Part D下的自付费用。结果显示原始医疗保险受益人1周自付649.24美元、3周1006.20美元,而Medigap G计划和医疗补助受益人自付为零。

要点

  • 原始医疗保险受益人1周放疗自付649.24美元,3周自付1006.20美元。
  • Medigap G计划受益人在假定乳房肿块切除术后免赔额已满足时,两种疗程均无额外自付费用。
  • 医疗补助受益人若治疗获批准,所有费用覆盖无上限,自付为零。

核心结论

  • 对于乳房肿块切除术后早期乳腺癌,选择1周还是3周放疗常取决于癌症特征和患者偏好。
  • 该模型基于各保险计划的实际费用估计而非理赔数据,比较了医疗补助和医疗保险计划下的自付费用,能更全面地帮助医生和患者在决定放疗疗程时做出决策。

研究设计与样本

  • 研究通过国家综合癌症网络指南确定治疗操作,使用Medicaid、Original Medicare、Medigap Plan G和Medicare Part D处方计划计算自付治疗费用、免赔额和共付/共保额。
  • 费用数据来源于medicare.gov、medicaid.oh.gov、aarpmedicareplans.com和cms.gov的医师费用表,所有操作均设定在俄亥俄州医院环境中进行。
  • 价格估计反映各保险计划的实际费用,而非基于理赔数据估计的费用。

主要发现

  • 拥有原始医疗保险的医疗保险受益人1周放疗的自付治疗费用为649.24美元,3周放疗为1006.20美元。
  • 假定肿块切除术后免赔额已满足,Medigap G计划受益人在1周和3周放疗中均无额外费用。
  • 类似地,医疗补助受益人(假定治疗获医疗补助批准)所有费用无上限覆盖,自付费用为零。

关键数值与推荐

  • 1周放疗定义为5次分割且不加 boost,3周放疗定义为15次分割且不加 boost。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: For early stage breast cancer (BC), the choice of radiation therapy duration (1 vs 3 weeks) is highly debated. Cost and financial toxicity are major concerns that patients with BC face. Nonetheless, there remain limited discussions providing granular details of the role of insurance in the aggregate cost of 1 week versus 3 weeks of radiation therapy for patients. This project aims to disaggregate costs by plan to increase transparency of out-of-pocket (OOP) cost estimates in radiation therapy. METHODS AND MATERIALS: Treatment procedures were determined through the National Comprehensive Cancer Network guidelines. OOP treatment costs, deductibles, and copays/coinsurance were calculated by using Medicaid, Original Medicare, Medigap Plan G, and Medicare Part D prescription plans. The medicare.gov, medicaid.oh.gov, aarpmedicareplans.com, and the physician fee schedule from cms.gov were used to determine costs by treatment. Price estimates reflect actual costs per insurance plan rather than costs estimated from claims data. All procedures were considered to be performed in an Ohio hospital setting. One-week radiation therapy was defined as 5 fractions without boost, and 3-week radiation therapy was defined as 15 fractions without boost. RESULTS: Medicare beneficiaries with Original Medicare coverage face an OOP treatment charge of $649.24 for 1 week of radiation therapy and $1006.20 for 3 weeks of radiation therapy. Assuming the deductible is met postlumpectomy, Medigap Plan G beneficiaries are faced with no additional charges for both lengths of radiation therapy. Similarly for Medicaid beneficiaries (assuming treatment is approved by Medicaid), all expenses are covered without limit, resulting in no OOP expense. CONCLUSIONS: Considerations of 1 and 3 weeks of radiation therapy for postlumpectomy early-stage BC are often dependent on cancer characteristics and patient preferences. This model (based on actual cost estimates per insurance plan rather than claims data) compares OOP costs across Medicaid and Medicare plans, which more holistically informs providers and patients in radiation therapy duration decision making.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wu VS, Khlopin M, Jagsi R, et al. Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration in Standard-of-Care Early Stage Breast Cancer Treatment Across Medicaid and Medicare Plans. Pract Radiat Oncol. 2023. PMID: 37748680. doi:10.1016/j.prro.2023.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。